Logo image of RDZN

ROADZEN INC (RDZN) Stock Fundamental Analysis

NASDAQ:RDZN - Nasdaq - VGG7606H1082 - Common Stock - Currency: USD

1.09  +0.03 (+2.83%)

After market: 1.12 +0.03 (+2.75%)

Fundamental Rating

1

Overall RDZN gets a fundamental rating of 1 out of 10. We evaluated RDZN against 284 industry peers in the Software industry. Both the profitability and financial health of RDZN have multiple concerns. RDZN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RDZN had negative earnings in the past year.
In the past year RDZN has reported a negative cash flow from operations.
RDZN had negative earnings in 4 of the past 5 years.
RDZN had a negative operating cash flow in each of the past 5 years.
RDZN Yearly Net Income VS EBIT VS OCF VS FCFRDZN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

RDZN has a Return On Assets of -333.46%. This is amonst the worse of the industry: RDZN underperforms 96.83% of its industry peers.
Industry RankSector Rank
ROA -333.46%
ROE N/A
ROIC N/A
ROA(3y)-57.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDZN Yearly ROA, ROE, ROICRDZN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

RDZN's Gross Margin of 59.46% is on the low side compared to the rest of the industry. RDZN is outperformed by 60.21% of its industry peers.
The Profit Margin and Operating Margin are not available for RDZN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RDZN Yearly Profit, Operating, Gross MarginsRDZN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

RDZN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RDZN has been increased compared to 1 year ago.
Compared to 1 year ago, RDZN has a worse debt to assets ratio.
RDZN Yearly Shares OutstandingRDZN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M
RDZN Yearly Total Debt VS Total AssetsRDZN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

RDZN has an Altman-Z score of -18.48. This is a bad value and indicates that RDZN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of RDZN (-18.48) is worse than 92.96% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -18.48
ROIC/WACCN/A
WACC8.5%
RDZN Yearly LT Debt VS Equity VS FCFRDZN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

RDZN has a Current Ratio of 0.42. This is a bad value and indicates that RDZN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.42, RDZN is doing worse than 91.90% of the companies in the same industry.
A Quick Ratio of 0.42 indicates that RDZN may have some problems paying its short term obligations.
RDZN has a Quick ratio of 0.42. This is amonst the worse of the industry: RDZN underperforms 91.55% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.42
RDZN Yearly Current Assets VS Current LiabilitesRDZN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

RDZN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -73.08%.
The Revenue has grown by 37.87% in the past year. This is a very strong growth!
EPS 1Y (TTM)-73.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.81%
Revenue 1Y (TTM)37.87%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-22.73%

3.2 Future

Based on estimates for the next years, RDZN will show a very strong growth in Earnings Per Share. The EPS will grow by 26.72% on average per year.
RDZN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 39.88% yearly.
EPS Next Y51.96%
EPS Next 2Y39.33%
EPS Next 3Y26.72%
EPS Next 5YN/A
Revenue Next Year-8.7%
Revenue Next 2Y18.47%
Revenue Next 3Y24.01%
Revenue Next 5Y39.88%

3.3 Evolution

RDZN Yearly Revenue VS EstimatesRDZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
RDZN Yearly EPS VS EstimatesRDZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -0.5 -1 -1.5 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RDZN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RDZN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RDZN Price Earnings VS Forward Price EarningsRDZN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RDZN Per share dataRDZN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

RDZN's earnings are expected to grow with 26.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.33%
EPS Next 3Y26.72%

More info and screens

0

5. Dividend

5.1 Amount

RDZN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROADZEN INC

NASDAQ:RDZN (6/27/2025, 8:00:02 PM)

After market: 1.12 +0.03 (+2.75%)

1.09

+0.03 (+2.83%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)07-07 2025-07-07
Inst Owners19.15%
Inst Owner Change-5.08%
Ins Owners3.77%
Ins Owner Change0.09%
Market Cap80.98M
Analysts82.5
Price Target5.61 (414.68%)
Short Float %4.42%
Short Ratio5.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)33.4%
Min EPS beat(2)10.36%
Max EPS beat(2)56.43%
EPS beat(4)2
Avg EPS beat(4)-15.7%
Min EPS beat(4)-98.88%
Max EPS beat(4)56.43%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.03%
Min Revenue beat(2)-7.9%
Max Revenue beat(2)-2.17%
Revenue beat(4)0
Avg Revenue beat(4)-12.68%
Min Revenue beat(4)-37.63%
Max Revenue beat(4)-2.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-8.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)4.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.89
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.51
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.58
BVpS-0.4
TBVpS-0.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -333.46%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.46%
FCFM N/A
ROA(3y)-57.02%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.34
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4.29%
Cap/Sales 0.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.42
Altman-Z -18.48
F-Score4
WACC8.5%
ROIC/WACCN/A
Cap/Depr(3y)50.54%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.81%
EPS Next Y51.96%
EPS Next 2Y39.33%
EPS Next 3Y26.72%
EPS Next 5YN/A
Revenue 1Y (TTM)37.87%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-22.73%
Revenue Next Year-8.7%
Revenue Next 2Y18.47%
Revenue Next 3Y24.01%
Revenue Next 5Y39.88%
EBIT growth 1Y-113.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year88.01%
EBIT Next 3Y30.18%
EBIT Next 5YN/A
FCF growth 1Y-763.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-759.06%
OCF growth 3YN/A
OCF growth 5YN/A